{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:21:35Z","timestamp":1776266495015,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["1"],"award-info":[{"award-number":["1"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Isabel Gemio","award":["1"],"award-info":[{"award-number":["1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00415-020-09872-7","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T18:03:58Z","timestamp":1588615438000},"page":"2546-2555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Persistent asymptomatic or mild symptomatic hyperCKemia due to mutations in ANO5: the mildest end of the anoctaminopathies spectrum"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-764X","authenticated-orcid":false,"given":"Lu\u00edsa","family":"Panad\u00e9s-de Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bermejo-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Pablo","family":"de Fuenmayor-Fern\u00e1ndez de la Hoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Cantero Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Hern\u00e1ndez Lain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Muelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Dom\u00ednguez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"9872_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/mus.25608","volume":"56","author":"C Papadopoulos","year":"2017","unstructured":"Papadopoulos C, Lafor\u00cat P, Nectoux J et al (2017) Hyperckemia and myalgia are common presentations of anoctamin-5-related myopathy in French patients: HyperCKemia and Myalgia in ANO5-Related Myopathy. Muscle Nerve 56:1096\u20131100. https:\/\/doi.org\/10.1002\/mus.25608","journal-title":"Muscle Nerve"},{"key":"9872_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ncl.2014.04.005","volume":"32","author":"MP Wicklund","year":"2014","unstructured":"Wicklund MP, Kissel JT (2014) The Limb-Girdle muscular dystrophies. Neurol Clin 32:729\u2013749. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.005","journal-title":"Neurol Clin"},{"key":"9872_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.nmd.2019.06.005","volume":"29","author":"S Cai","year":"2019","unstructured":"Cai S, Gao M, Xi J et al (2019) Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy. Neuromuscul Disord 29:628\u2013633. https:\/\/doi.org\/10.1016\/j.nmd.2019.06.005","journal-title":"Neuromuscul Disord"},{"key":"9872_CR4","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.nmd.2012.05.012","volume":"22","author":"A Sarkozy","year":"2012","unstructured":"Sarkozy A, Deschauer M, Carlier R-Y et al (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 22:S122\u2013S129. https:\/\/doi.org\/10.1016\/j.nmd.2012.05.012","journal-title":"Neuromuscul Disord"},{"key":"9872_CR5","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1016\/j.nmd.2012.02.007","volume":"22","author":"I Mahjneh","year":"2012","unstructured":"Mahjneh I, Bashir R, Kiuru-Enari S et al (2012) Selective pattern of muscle involvement seen in distal muscular dystrophy associated with anoctamin 5 mutations: a follow-up muscle MRI study. Neuromuscul Disord 22:S130\u2013S136. https:\/\/doi.org\/10.1016\/j.nmd.2012.02.007","journal-title":"Neuromuscul Disord"},{"key":"9872_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s00415-019-09217-z","volume":"266","author":"L Panad\u00e9s-de Oliveira","year":"2019","unstructured":"Panad\u00e9s-de Oliveira L, Rodr\u00edguez-L\u00f3pez C, Cantero Montenegro D et al (2019) Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. J Neurol 266:934\u2013941. https:\/\/doi.org\/10.1007\/s00415-019-09217-z","journal-title":"J Neurol"},{"key":"9872_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013423. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"9872_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2009.12.013","volume":"86","author":"V Bolduc","year":"2010","unstructured":"Bolduc V, Marlow G, Boycott KM et al (2010) Recessive mutations in the putative calcium-activated chloride channel anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 86:213\u2013221. https:\/\/doi.org\/10.1016\/j.ajhg.2009.12.013","journal-title":"Am J Hum Genet"},{"key":"9872_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/mus.23281","volume":"45","author":"J Schessl","year":"2012","unstructured":"Schessl J, Kress W, Schoser B (2012) Novel ANO5 mutations causing hyperCKemia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy: short reports. Muscle Nerve 45:740\u2013742. https:\/\/doi.org\/10.1002\/mus.23281","journal-title":"Muscle Nerve"},{"key":"9872_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.nmd.2012.05.001","volume":"22","author":"F Magri","year":"2012","unstructured":"Magri F, Bo RD, D\u2019Angelo MG et al (2012) Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients. Neuromuscul Disord 22:934\u2013943. https:\/\/doi.org\/10.1016\/j.nmd.2012.05.001","journal-title":"Neuromuscul Disord"},{"key":"9872_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1212\/WNL.0b013e31824c4682","volume":"78","author":"S Penttil\u00e4","year":"2012","unstructured":"Penttil\u00e4 S, Palmio J, Suominen T et al (2012) Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5. Neurology 78:897\u2013903. https:\/\/doi.org\/10.1212\/WNL.0b013e31824c4682","journal-title":"Neurology"},{"key":"9872_CR12","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1212\/NXG.0000000000000352","volume":"5","author":"A Rubegni","year":"2019","unstructured":"Rubegni A, Malandrini A, Dosi C et al (2019) Next-generation sequencing approach to hyperCKemia: a 2-year cohort study. Neurol Genet 5:e352. https:\/\/doi.org\/10.1212\/NXG.0000000000000352","journal-title":"Neurol Genet"},{"key":"9872_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/acn3.50801","volume":"6","author":"AMS Silva","year":"2019","unstructured":"Silva AMS, Coimbra-Neto AR, Souza PVS et al (2019) Clinical and molecular findings in a cohort of ANO5 -related myopathy. Ann Clin Trans Neurol 6:1225\u20131238. https:\/\/doi.org\/10.1002\/acn3.50801","journal-title":"Ann Clin Trans Neurol"},{"key":"9872_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0022-510X(96)00037-8","volume":"143","author":"CD Reimers","year":"1996","unstructured":"Reimers CD, Schlotter B, Eicke BM, Witt TN (1996) Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature. J Neurol Sci 143:46\u201356. https:\/\/doi.org\/10.1016\/S0022-510X(96)00037-8","journal-title":"J Neurol Sci"},{"key":"9872_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nmd.2011.07.005","volume":"22","author":"M Milone","year":"2012","unstructured":"Milone M, Liewluck T, Winder TL, Pianosi PT (2012) Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul Disord 22:13\u201315. https:\/\/doi.org\/10.1016\/j.nmd.2011.07.005","journal-title":"Neuromuscul Disord"},{"key":"9872_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1469-8749.2012.04320.x","volume":"54","author":"R Quinlivan","year":"2012","unstructured":"Quinlivan R, Jungbluth H (2012) Myopathic causes of exercise intolerance with rhabdomyolysis: review. Dev Med Child Neurol 54:886\u2013891. https:\/\/doi.org\/10.1111\/j.1469-8749.2012.04320.x","journal-title":"Dev Med Child Neurol"},{"key":"9872_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.nmd.2016.05.006","volume":"26","author":"RS Scalco","year":"2016","unstructured":"Scalco RS, Gardiner AR, Pitceathly RDS et al (2016) CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: expanding the phenotypic spectrum of caveolinopathies. Neuromuscul Disord 26:504\u2013510. https:\/\/doi.org\/10.1016\/j.nmd.2016.05.006","journal-title":"Neuromuscul Disord"},{"key":"9872_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-08-045031-5.00006-2","volume-title":"Limb-girdle muscular dystrophy 2A. In: Handbook of clinical neurology","author":"E Gallardo","year":"2011","unstructured":"Gallardo E, Saenz A, Illa I (2011) Limb-girdle muscular dystrophy 2A. In: Handbook of clinical neurology. Elsevier, Amsterdam, pp 97\u2013110"},{"key":"9872_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.4103\/0028-3886.149386","volume":"62","author":"M Krahn","year":"2014","unstructured":"Krahn M, Beroud C, Xi J et al (2014) Clinical heterogeneity and a high proportion of novel mutations in a Chinese cohort of patients with dysferlinopathy. Neurol India 62:635. https:\/\/doi.org\/10.4103\/0028-3886.149386","journal-title":"Neurol India"},{"key":"9872_CR20","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/humu.22342","volume":"34","author":"A Sarkozy","year":"2013","unstructured":"Sarkozy A, Hicks D, Hudson J et al (2013) ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. Hum Mutat 34:1111\u20131118. https:\/\/doi.org\/10.1002\/humu.22342","journal-title":"Hum Mutat"},{"key":"9872_CR21","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00415-013-6934-y","volume":"260","author":"N Witting","year":"2013","unstructured":"Witting N, Duno M, Petri H et al (2013) Anoctamin 5 muscular dystrophy in Denmark: prevalence, genotypes, phenotypes, cardiac findings, and muscle protein expression. J Neurol 260:2084\u20132093. https:\/\/doi.org\/10.1007\/s00415-013-6934-y","journal-title":"J Neurol"},{"key":"9872_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nmd.2015.03.011","volume":"25","author":"M Savarese","year":"2015","unstructured":"Savarese M, Di Fruscio G, Tasca G et al (2015) Next generation sequencing on patients with LGMD and nonspecific myopathies: findings associated with ANO5 mutations. Neuromuscul Disord 25:533\u2013541. https:\/\/doi.org\/10.1016\/j.nmd.2015.03.011","journal-title":"Neuromuscul Disord"},{"key":"9872_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10875-010-9474-6","volume":"31","author":"G Frisullo","year":"2011","unstructured":"Frisullo G, Frusciante R, Nociti V et al (2011) CD8+ T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol 31:155\u2013166. https:\/\/doi.org\/10.1007\/s10875-010-9474-6","journal-title":"J Clin Immunol"},{"key":"9872_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/s0140-6736(94)92263-2","volume":"344","author":"RB Fitzsimons","year":"1994","unstructured":"Fitzsimons RB (1994) Facioscapulohumeral dystrophy: the role of inflammation. Lancet 344:902\u2013903. https:\/\/doi.org\/10.1016\/s0140-6736(94)92263-2","journal-title":"Lancet"},{"key":"9872_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jns.2015.03.001","volume":"351","author":"R Dabby","year":"2015","unstructured":"Dabby R, Sadeh M, Hilton-Jones D et al (2015) Adult onset limb-girdle muscular dystrophy\u2014a recessive titinopathy masquerading as myositis. J Neurol Sci 351:120\u2013123. https:\/\/doi.org\/10.1016\/j.jns.2015.03.001","journal-title":"J Neurol Sci"},{"key":"9872_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.nmd.2019.08.011","volume":"29","author":"J Warman Chardon","year":"2019","unstructured":"Warman Chardon J, D\u00edaz-Manera J, Tasca G et al (2019) MYO-MRI diagnostic protocols in genetic myopathies. Neuromuscul Disord 29:827\u2013841. https:\/\/doi.org\/10.1016\/j.nmd.2019.08.011","journal-title":"Neuromuscul Disord"},{"key":"9872_CR27","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00415-019-09242-y","volume":"266","author":"JR Dahlqvist","year":"2019","unstructured":"Dahlqvist JR, Andersen G, Khawajazada T et al (2019) Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy. J Neurol 266:1127\u20131135. https:\/\/doi.org\/10.1007\/s00415-019-09242-y","journal-title":"J Neurol"},{"key":"9872_CR28","first-page":"127","volume":"30","author":"C Angelini","year":"2011","unstructured":"Angelini C, Peterle E, Gaiani A et al (2011) Dysferlinopathy course and sportive activity: clues for possible treatment. Acta Myol 30:127\u2013132","journal-title":"Acta Myol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09872-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09872-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09872-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T23:51:16Z","timestamp":1620085876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09872-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9872"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09872-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}